Sleep product firms' results benefit from expanding markets
This article was originally published in Clinica
Executive Summary
Beckman Coulter's sales growth came from positive currency effects, new product contributions and general growth in hardware and installation business. Clinical diagnostics grew by 17%, and the new UniCel Dxl 800 Access immunoassay system for high-volume labs is expected to provide continuing momentum. The company's net income was adversely affected by restructuring charges associated with the creation of the biomedical research division, among other things.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.